A Denmark-based pharmaceutical manufacturer focused on diabetes care, obesity treatments, and other chronic diseases, with a portfolio anchored by insulin products and GLP-1 therapies such as Ozempic and Wegovy. The company generates the majority of its revenue from treatments for diabetes and weight management, making it a central player in the rapidly expanding metabolic disease market. Investors closely monitor prescription growth, pricing dynamics, and clinical pipeline developments given the outsized earnings impact of its obesity franchise.
13 members of Congress have disclosed 50 trades in Novo Nordisk A/S (NVO), a Healthcare company. The buy/sell breakdown shows 31 purchases versus 19 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-30 | Alan Armstrong | buy | $15K – $50K |
| 2026-03-13 | Rohit Khanna | buy | $1K – $15K |
| 2026-02-13 | Rohit Khanna | buy | $1K – $15K |
| 2025-10-31 | Lisa McClain | sell | $1K – $15K |
| 2025-10-30 | Lisa McClain | buy | $1K – $15K |
| 2025-10-30 | Lisa McClain | sell | $1K – $15K |
| 2025-10-15 | Marjorie Taylor Greene | buy | $1K – $15K |
| 2025-09-11 | Lisa McClain | buy | $1K – $15K |
| 2025-09-11 | Lisa McClain | buy | $1K – $15K |
| 2025-08-28 | Marjorie Taylor Greene | buy | $1K – $15K |
| 2025-08-19 | Marjorie Taylor Greene | buy | $15K – $50K |
| 2025-08-04 | Scott Franklin | buy | $1K – $15K |
| 2025-08-04 | Scott Franklin | buy | $1K – $15K |
| 2025-08-04 | Lisa McClain | sell | $1K – $15K |
| 2025-08-04 | Scott Franklin | buy | $15K – $50K |
| 2025-08-04 | Scott Franklin | buy | $1K – $15K |
| 2025-07-10 | Lisa McClain | sell | $1K – $15K |
| 2025-06-16 | MICHAEL T. MCCAUL | buy | $50K – $100K |
| 2025-06-09 | Lisa McClain | buy | $1K – $15K |
| 2025-05-08 | Laurel Lee | sell | $1K – $15K |
| 2025-03-27 | Scott Franklin | buy | $1K – $15K |
| 2025-03-27 | Scott Franklin | buy | $15K – $50K |
| 2025-03-20 | Byron Donalds | sell | $1K – $15K |
| 2025-03-20 | Byron Donalds | sell | $1K – $15K |
| 2024-12-23 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2024-12-23 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2024-11-04 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2024-10-29 | Valerie Hoyle | buy | $1K – $15K |
| 2024-10-21 | MICHAEL T. MCCAUL | buy | $15K – $50K |
| 2024-09-04 | John James | sell | $1K – $15K |
| 2024-08-26 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2024-08-26 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2024-08-09 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2024-08-09 | MICHAEL T. MCCAUL | buy | $15K – $50K |
| 2024-07-12 | Rohit Khanna | buy | $1K – $15K |
| 2024-05-28 | MICHAEL T. MCCAUL | buy | $50K – $100K |
| 2024-04-24 | MICHAEL T. MCCAUL | buy | $50K – $100K |
| 2024-04-24 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2024-04-23 | MICHAEL T. MCCAUL | buy | $50K – $100K |
| 2024-04-23 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2024-01-19 | Thomas H Tuberville | sell | $15K – $50K |
| 2023-12-06 | Rohit Khanna | sell | $1K – $15K |
| 2023-11-10 | John James | buy | $1K – $15K |
| 2023-07-12 | Daniel Goldman | sell | $100K – $250K |
| 2023-07-10 | Daniel Goldman | sell | $250K – $500K |
| 2023-06-12 | Rohit Khanna | buy | $1K – $15K |
| 2022-10-07 | Byron Donalds | buy | $1K – $15K |
| 2022-10-07 | Byron Donalds | sell | $1K – $15K |
| 2021-09-16 | KATHERINE CLARK | sell | $1K – $15K |
| 2020-11-05 | KATHERINE CLARK | buy | $1K – $15K |